Patent · US Active

REIC-expressing adenovirus vector

US9222107B2 · kind B2 · utility

3Cited by
3References
8Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 25, 2012
Grant dateDec 29, 2015
Priority date
Expiry dateMay 25, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2830/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An objective of the present invention is to provide an adenovirus vector expressing a REIC/Dkk-3 protein at a high level and containing a DNA construct for expression of REIC/Dkk-3 DNA, wherein the DNA construct is prepared by ligating, from the 5′ terminal side,

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.